Binocular and accommodative function in the controlled randomized clinical trial MiSight® Assessment Study Spain (MASS)

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):207-215. doi: 10.1007/s00417-018-4115-5. Epub 2018 Sep 8.

Abstract

Purpose: To evaluate the binocular and accommodative function in children wearing dual focus (DF) MiSight® contact lenses (CLs) for myopia control compared with children wearing single-vision (SV) spectacles.

Methods: This was a randomized, controlled clinical trial involving subjects aged 8 to 12, with myopia ranging from - 0.75 to - 4.00D and astigmatism < 1.00D, allocated to MiSight® study CLs group or control group wearing SV. Binocular and accommodative function was determined at baseline, 12-, and 24-month visits, assessed by the following sequence of tests: distance and near horizontal phoria, accommodative convergence/accommodation (AC/A) ratio, stereopsis, accommodative amplitude (AA), and accommodative response (AR) at 33, 25 and 20 cm.

Results: Seventy-four children completed the study: 41 in the CL group and 33 in the SV group. CLs group did not show any significant differences in binocular and accommodative measurements throughout the study. In control group, distance and near phoria, stereopsis, AC/A and AR at 20 cm did not show any significant change, but AA, AR at 33 cm and AR at 25 cm were greater at 24-month visit compared with baseline (p < 0.05).

Conclusions: DF lenses do not change the binocular and accommodative function in children wearing dual focus CLs.

Trial registration: NCT01917110.

Keywords: Accommodation; Binocular vision; Children; Dual focus contact lenses.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Accommodation, Ocular / physiology*
  • Child
  • Contact Lenses, Hydrophilic*
  • Eyeglasses*
  • Female
  • Humans
  • Male
  • Myopia / physiopathology
  • Myopia / therapy*
  • Refraction, Ocular / physiology*
  • Spain
  • Treatment Outcome
  • Vision, Binocular / physiology*
  • Visual Acuity*

Associated data

  • ClinicalTrials.gov/NCT01917110